Clindamycin phosphate and Robaxin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clindamycin phosphate (clindamycin phosphate) and Robaxin (methocarbamol). Common drug interactions include conjunctivitis among females and incisional hernia among males.

The phase IV clinical study analyzes what interactions people have when they take Clindamycin phosphate and Robaxin. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Clindamycin phosphate?

Clindamycin phosphate has active ingredients of clindamycin phosphate. It is often used in infection. eHealthMe is studying from 4,216 Clindamycin phosphate users. Check the latest studies of Clindamycin phosphate.

What is Robaxin?

Robaxin has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 9,109 Robaxin users. Check the latest studies of Robaxin.



On Jul, 11, 2026

16 people who take Clindamycin phosphate and Robaxin together, and have interactions are studied.

Clindamycin phosphate and Robaxin drug interactions.

What are the common drug interactions of Clindamycin Phosphate and Robaxin, by gender? *:

female:

  1. Conjunctivitis (pink eye)
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Depression
  4. Drug hypersensitivity
  5. Dyspnoea (difficult or laboured respiration)
  6. Ear infection
  7. Eye discharge
  8. Fear of disease
  9. Fungal infection
  10. Gestational diabetes (diabetes in pregnancy)

male:

  1. Incisional hernia (hernia caused by an incompletely-healed surgical wound)
  2. Renal cancer (cancer of kidney)

What are the common drug interactions of Clindamycin Phosphate and Robaxin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Depression
  5. Dyspnoea (difficult or laboured respiration)
  6. Fear of disease
  7. Pain in extremity
  8. Pulmonary embolism (blockage of the main artery of the lung)

40-49:

  1. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  3. Hysterectomy

50-59:

  1. Incisional hernia (hernia caused by an incompletely-healed surgical wound)
  2. Renal cancer (cancer of kidney)

60+:

  1. Asthma
  2. Conjunctivitis (pink eye)
  3. Drug hypersensitivity
  4. Ear infection
  5. Eye discharge
  6. Fungal infection
  7. Influenza
  8. Ocular hyperaemia (an abnormally large amount of blood in eye)
  9. Pneumonia
  10. Urticaria (rash of round, red welts on the skin that itch intensely)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 11 people, 68.75%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 9 people, 56.25%
  3. Sleep Disorder: 1 person, 6.25%
  4. High Blood Pressure: 1 person, 6.25%
  5. Back Pain: 1 person, 6.25%
  6. Birth Control: 1 person, 6.25%
  7. Bladder Spasm: 1 person, 6.25%
  8. Constipation: 1 person, 6.25%
  9. Drowsiness: 1 person, 6.25%
  10. Headache (pain in head): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Clindamycin phosphate and Robaxin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Clindamycin phosphate and Robaxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clindamycin phosphate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Robaxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clindamycin phosphate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Robaxin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on clindamycin phosphate and methocarbamol (the active ingredients of Clindamycin phosphate and Robaxin, respectively), and Clindamycin phosphate and Robaxin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: